Company News
Summit Therapeutics $500M Offering Causes 12% Drop
Summit Therapeutics announced a proposed $500 million common stock offering, with an additional $75 million over‑allotment option.
Shares of Nasdaq‑listed SMMT fell 12% after market close on Tuesday f
